New imaging software improves lung diagnosis for 30% of patients who can’t tolerate contrast dye; has added diagnostic benefits for all patients

For up to 30% of patients who are allergic to medical contrast dye or have a dye restriction because of other health conditions, they might find that it takes longer to get a diagnosis when it comes to life-threatening lung issues such as pulmonary embolism.